Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study of Pregabalin in Fibromyalgia

ClinicalTrials.gov ID: NCT00151489

Public ClinicalTrials.gov record NCT00151489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia

Study identification

NCT ID
NCT00151489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
1,020 participants

Conditions and interventions

Conditions

Interventions

  • placebo Drug
  • pregabalin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2005
Primary completion
Not listed
Completion
May 31, 2006
Last update posted
Jan 21, 2021

2005 – 2006

United States locations

U.S. sites
109
U.S. states
36
U.S. cities
94
Facility City State ZIP Site status
Pfizer Investigational Site Anniston Alabama 36207
Pfizer Investigational Site Birmingham Alabama 35235
Pfizer Investigational Site Calera Alabama 35040
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Tuscaloosa Alabama 35406
Pfizer Investigational Site Phoenix Arizona 85013
Pfizer Investigational Site Phoenix Arizona 85023
Pfizer Investigational Site Scottsdale Arizona 85251
Pfizer Investigational Site Fayetteville Arkansas 72703
Pfizer Investigational Site Hot Springs Arkansas 71913
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Carmichael California 95608
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site Los Alamitos California 90720
Pfizer Investigational Site Northridge California 91324
Pfizer Investigational Site Pismo Beach California 93449
Pfizer Investigational Site Santa Ana California 92705
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Whittier California 90601
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Stratford Connecticut 06615
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site Washington D.C. District of Columbia 20010
Pfizer Investigational Site Chiefland Florida 32680
Pfizer Investigational Site Clearwater Florida 33761
Pfizer Investigational Site Kissimmee Florida 34741
Pfizer Investigational Site Miami Florida 33173
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Palm Harbor Florida 34684
Pfizer Investigational Site Palm Springs Florida 33461
Pfizer Investigational Site Plantation Florida 33317
Pfizer Investigational Site Plantation Florida 33324
Pfizer Investigational Site St. Petersburg Florida 33709
Pfizer Investigational Site Sunrise Florida 33351
Pfizer Investigational Site Tampa Florida 33609
Pfizer Investigational Site West Palm Beach Florida 33409
Pfizer Investigational Site Atlanta Georgia 30328
Pfizer Investigational Site Gurnee Illinois 60031
Pfizer Investigational Site Peoria Illinois 61614
Pfizer Investigational Site Evansville Indiana 47712
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Indianapolis Indiana 46254
Pfizer Investigational Site Prairie Village Kansas 66206
Pfizer Investigational Site Lexington Kentucky 40509
Pfizer Investigational Site Lexington Kentucky 40536-0284
Pfizer Investigational Site Lexington Kentucky 40536
Pfizer Investigational Site Owensboro Kentucky 42303
Pfizer Investigational Site Baton Rouge Louisiana 70809
Pfizer Investigational Site New Orleans Louisiana 70114
Pfizer Investigational Site New Orleans Louisiana 70128
Pfizer Investigational Site Springfield Massachusetts 01107
Pfizer Investigational Site Worcester Massachusetts 01610
Pfizer Investigational Site Kalamazoo Michigan 49009
Pfizer Investigational Site Lansing Michigan 48917
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Jackson Mississippi 39202
Pfizer Investigational Site Blue Springs Missouri 64014
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Henderson Nevada 89014
Pfizer Investigational Site Cherry Hill New Jersey 08002
Pfizer Investigational Site Edison New Jersey 08817
Pfizer Investigational Site Highland Park New Jersey 08904
Pfizer Investigational Site Ridgewood New Jersey 07450
Pfizer Investigational Site South Eddison New Jersey 08817
Pfizer Investigational Site Albany New York 12205
Pfizer Investigational Site Johnson City New York 13790
Pfizer Investigational Site Rochester New York 14618
Pfizer Investigational Site Smithtown New York 11787-2817
Pfizer Investigational Site Charlotte North Carolina 28207
Pfizer Investigational Site Charlotte North Carolina 28209
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Raleigh North Carolina 27612
Pfizer Investigational Site Salisbury North Carolina 28144
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Columbus Ohio 43212
Pfizer Investigational Site Mogadore Ohio 44260
Pfizer Investigational Site Toledo Ohio 43623
Pfizer Investigational Site Tulsa Oklahoma 74104
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Bensalem Pennsylvania 19020
Pfizer Investigational Site Mechanicsburg Pennsylvania 17055
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Pittsburgh Pennsylvania 15218
Pfizer Investigational Site West Reading Pennsylvania 19611-1124
Pfizer Investigational Site Charleston South Carolina 29406
Pfizer Investigational Site Greenville South Carolina 29601
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Sioux Falls South Dakota 57105
Pfizer Investigational Site Memphis Tennessee 38119
Pfizer Investigational Site Nashville Tennessee 37207
Pfizer Investigational Site Austin Texas 78705
Pfizer Investigational Site Fort Worth Texas 76107
Pfizer Investigational Site San Antonio Texas 78217
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Layton Utah 84041
Pfizer Investigational Site Layton Utah 841041
Pfizer Investigational Site Salt Lake City Utah 84107
Pfizer Investigational Site South Jordan Utah 84095
Pfizer Investigational Site Virginia Beach Virginia 23454
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Seattle Washington 98104
Pfizer Investigational Site Seattle Washington 98122
Pfizer Investigational Site Seattle Washington 98166-2967
Pfizer Investigational Site Spokane Washington 99204
Pfizer Investigational Site Yakima Washington 98902
Pfizer Investigational Site Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00151489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2021 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00151489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →